2015 American Transplant Congress
B-Cell Activation in Acute Kidney Injury and Delayed Graft Function
Background:Acute kidney injury (AKI) is a relevant complication after kidney transplantation and also after non-renal solid organ transplantation. Growing evidence points towards an important role…2015 American Transplant Congress
Lessons Learned from the Clinical Use of Normothermic Regional Perfusion (nRP) in Uncontrolled Donation After Circulatory Death (DCD)
The national protocol for the uDCD program restricts donor age < 55 y, no flow period < 30 min and total warm ischemia time (WIT)…2015 American Transplant Congress
Evolution of GFR Outcomes During the First Year of Transplant According to the Kidney Donor Risk Index Transplantation in México. The Experience of a Single Center
Several scoring systems have been proposed to evaluate the quality of kidneys from deceased donors (DD). Recently, Kidney Donor Risk Index (KDRI) was introduced in…2015 American Transplant Congress
No Pharmacokinetic Interaction Between Pantoprazole and Mycophenolic Acid in Renal Transplant Patents: A Randomized Crossover Study
Department of Nephrology, Charité University Hospital, Berlin, Germany.
Mycophenolic acid (MPA) is used as an immunosuppressive agent in renal transplant (tx) patients (pts). 2 formulations are on the market: The prodrug Mycophenolate-Mofetil (MMF)…2015 American Transplant Congress
Heterologous Immune Responses to Influenza Vaccine in Kidney Transplant Recipients
Background:Influenza vaccine is known to have suboptimal immunogenicity in transplant recipients. However, influenza vaccine may have the added benefit of inducing a cross-reactive immune response…2015 American Transplant Congress
Validation of the Early Postoperative labMELD as Predictor of Outcome After Transplantation of Extended Criteria Donor Livers
Background:Since there is no generally accepted standard definition of early allograft dysfunction (EAD) after liver transplantation, we recently suggested postoperative labMELD as predictor for outcome…2015 American Transplant Congress
Nonalcoholic Steatohepatitis as Indication for Liver Transplantation in Europe. Do We Choose the Right Organs for the Right Recipients?
Background:Nonalcoholic steatohepatitis (NASH) has emerged to become the third leading cause for liver transplantation (LT) in the US and since 2002, it has increased constantly.Methods:We…2015 American Transplant Congress
Prediction of Post-Operative Length of Stay and Unplanned Reoperation in Patients Transplanted for Alcoholic Liver Disease: An Artificial Neural Network Approach
Surgery, Vanderbilt University, Nashville, TN.
Purpose:Using artificial neural network (ANN) modeling, this study aims to optimize the prediction of prolonged length of stay (LOS) and need for unplanned reoperation (UR)…2015 American Transplant Congress
The Burden of Caregiving for Living Kidney Donors
Renal Transplantation, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.
Introduction: A large number of kidney donors are also primary caregivers for their recipients. Whilst primary caregiver status is a well-established cause of psychopathology, it…2015 American Transplant Congress
Can We Use MDRD or CKD-EPI Equation for Donor Selection?
Renal Transplantation Service, Hospital das Clínicas-FMUSP, Sao Paulo, Brazil.
INTRODUCTION: Determination of the glomerular filtration rate (GFR) is critical for the selection of a potential living kidney donor. Since July 2008 our center has…
- « Previous Page
- 1
- …
- 59
- 60
- 61
- 62
- 63
- …
- 170
- Next Page »